Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart
A Kinoshita1, H Urata, F M Bumpus
1Department of Heart and Hypertension Research, Research Institute of the Cleveland Clinic Foundation, Ohio 44195-5069.
Insights
Human heart chymase efficiently forms angiotensin II (Ang II) by cleaving angiotensin I (Ang I). Its substrate specificity is defined by aromatic amino acids at P1 and proline at S2, guiding ideal substrate design.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Human heart chymase is a specific serine proteinase.
- It efficiently generates angiotensin II (Ang II) from angiotensin I (Ang I).
- Other chymases exhibit broader substrate specificity.
Purpose of the Study:
- To define the substrate-binding site of human heart chymase.
- To elucidate the enzyme's substrate specificity using Ang I analogs.
Main Methods:
- Mapping the extended substrate-binding site of human heart chymase.
- Utilizing Ang I analogs to probe enzyme-substrate interactions.
Main Results:
- Human heart chymase prefers aromatic amino acids (phenylalanine, tyrosine, tryptophan) at the P1 site.
- A significant preference for proline at the S2 subsite was observed.
- Substrate hydrolysis is sensitive to amino acid deletions and leaving group length.
Conclusions:
- Human heart chymase exhibits restricted substrate specificity compared to other chymases.
- Ideal substrates contain a specific sequence: nXaa-Pro-[Phe, Tyr, or Trp]-Yaa-Yaa (n≥6).
- This specificity is crucial for understanding Ang II formation and related physiological processes.
Abstract:
Human heart chymase, a chymotrypsin-like serine proteinase that hydrolyzes the Phe8-His9 bond in angiotensin I (Ang I) to yield the octapeptide hormone angiotensin II (Ang II) and His-Leu, is the most specific, efficient Ang II-forming enzyme described. Other mammalian chymases display a much broader substrate specificity. To better define its substrate specificity, we have mapped the extended substrate-binding site of human heart chymase using Ang I analogs. The enzyme has a preference for aromatic amino acids phenylalanine, tyrosine, and tryptophan at the P1 site. At the S2 subsite there is a significant preference for proline over hydrophobic or hydrophilic amino acids. There is no clear preference for hydrophobic or hydrophilic amino acids at the S'1 and S'2 subsites, but an Ang I analog containing a P'1 proline is not hydrolyzed and one with a P'2 proline is hydrolyzed poorly. An increasing reduction in reactivity occurs when the P position amino acids in Ang I are deleted sequentially from the N terminus. An increase or decrease in the length of the His-Leu leaving group also produces a marked decrease in reactivity. No single determinant in Ang I is preeminently required for efficient catalysis, but several factors acting synergistically appear to be important. Thus, we propose that ideal substrates for human heart chymase should contain the structure nXaa-Pro-[Phe, Tyr, or Trp]-Yaa-Yaa, where n greater than or equal to 6; Xaa = any amino acid; Yaa = any amino acid except proline. This structure exists in Ang I and neurotensin, both of which are good substrates for human heart chymase. These findings indicate that the selection of the scissile bond by the extended substrate-binding site of human heart chymase is more restricted than that in other chymases.
More Related Videos
Related Concept Videos
Ligand Binding and Linkage
Introduction to Mechanisms of Enzyme Catalysis
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System


